Idiopathic Pulmonary Fibrosis (IPF)Genetics
What this study is
This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.
What's being tested
- Blood draw
Intervention · OTHER
Blood draw
- Questionnaire
Intervention · OTHER
Pulmonary Fibrosis Questionnaire
Study details
- Official title
- Idiopathic Pulmonary Fibrosis, a Disease Initiated by Mucociliary Dysfunction
- Sponsor
- University of Colorado, Denver
- Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
- Enrolling
- 1,000 people
- Starts
- 2018-01-18
- Est. completion
- 2026-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Age at least 18 years old
- Family member diagnosed with IPF
You can't join if
- No family member with IPF
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
- Rachel Warren, BA · Contact303-724-8569rachel.bochantin@ucdenver.edu
- Maria Rodriguez, BA · Contact303-724-0738
Recruiting
Study team
Sponsor
University of Colorado, Denver
Study ID 15-1147
Principal investigator
David A Schwartz, MD
University of Colorado, Denver
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.